ArticleAnalytical and bioanalytical chemistry2026
Resolving the issue of non-specific substrate oxidation in nanozyme-assisted colorimetric assays.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nanoparticles exhibiting peroxidase-like activity (nanozymes) are emerging as promising alternatives to enzyme labels in colorimetric assays, including ELISA. Unlike natural peroxidases, nanozymes demonstrate distinct mechanisms for oxidizing chromogenic substrates such as 3,3',5,5'-tetramethylbenzidine (TMB), prompting the use of custom substrate formulations in contemporary research. However, analysis of the literature reveals that such compositions often yield abnormally high background signals due to non-specific oxidation of TMB, likely catalyzed by trace metal ions present in assay buffers. This phenomenon narrows the dynamic range, elevates limits of detection (LOD), and restricts the use of higher substrate concentrations that could otherwise enhance assay sensitivity. In this study, we identify the widespread use of sodium acetate buffer as a principal contributor to non-specific oxidation, owing to its limited chelating capacity. Statistical analysis demonstrates that lower pH, elevated TMB concentration, and, to a lesser extent, increased buffer molarity and hydrogen peroxide concentration are the most significant factors promoting non-specific reactions. Additional variables influencing the background include reagent purity and organic co-solvent content. Employing platinum nanozymes as a model system, we propose two effective strategies to mitigate non-specific oxidation: (i) substitution of acetate buffer with citrate buffer and (ii) supplementation of acetate buffer with chelating agents. These approaches reduce LOD by 3-12-fold while maintaining low background signals even under adverse conditions (high TMB concentration and low pH).
Indexed as
Identifiers
42429935What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.